ECSP10010532A - Tiazolil-dihidro-indazoles - Google Patents
Tiazolil-dihidro-indazolesInfo
- Publication number
- ECSP10010532A ECSP10010532A EC2010010532A ECSP10010532A ECSP10010532A EC SP10010532 A ECSP10010532 A EC SP10010532A EC 2010010532 A EC2010010532 A EC 2010010532A EC SP10010532 A ECSP10010532 A EC SP10010532A EC SP10010532 A ECSP10010532 A EC SP10010532A
- Authority
- EC
- Ecuador
- Prior art keywords
- tiazolil
- dihidro
- indazoles
- medicine
- excessive
- Prior art date
Links
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La presente invencion comprende compuestos de formula general (1)en la cualR1 hasta R3 estan definidos como en la reivindicacion 1, que son adecuados para el tratamiento de enfermedades caracterizadas por una proliferacion celular excesiva o anormal, y el uso de los mismos para preparar un medicamento que tenga las propiedades antes mencionadas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08152721 | 2008-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP10010532A true ECSP10010532A (es) | 2010-11-30 |
Family
ID=39591172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2010010532A ECSP10010532A (es) | 2008-03-13 | 2010-10-08 | Tiazolil-dihidro-indazoles |
Country Status (21)
Country | Link |
---|---|
US (2) | US20110118208A1 (es) |
EP (1) | EP2280982A1 (es) |
JP (1) | JP2011513471A (es) |
KR (1) | KR20100135743A (es) |
CN (1) | CN102015728A (es) |
AR (1) | AR070877A1 (es) |
AU (1) | AU2009224659A1 (es) |
BR (1) | BRPI0908583A2 (es) |
CA (1) | CA2717488A1 (es) |
CL (1) | CL2009000599A1 (es) |
CO (1) | CO6290768A2 (es) |
EA (1) | EA201001427A1 (es) |
EC (1) | ECSP10010532A (es) |
IL (1) | IL207776A0 (es) |
MA (1) | MA32158B1 (es) |
MX (1) | MX2010009837A (es) |
PE (1) | PE20091617A1 (es) |
TW (1) | TW200942548A (es) |
UY (1) | UY31700A (es) |
WO (1) | WO2009112565A1 (es) |
ZA (1) | ZA201006023B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011049625A1 (en) | 2009-10-20 | 2011-04-28 | Mansour Samadpour | Method for aflatoxin screening of products |
AP2012006294A0 (en) | 2009-11-05 | 2012-06-30 | Rhizen Pharmaceuticals Sa | Novel kinase modulators. |
TW201245176A (en) * | 2011-01-26 | 2012-11-16 | Boehringer Ingelheim Int | New 5-alkynyl-pyridines |
EP2546249A1 (en) | 2011-07-15 | 2013-01-16 | Boehringer Ingelheim International Gmbh | 5-Alkynyl-pyridines |
US8466162B2 (en) | 2011-01-26 | 2013-06-18 | Boehringer Ingelheim International Gmbh | 5-alkynyl-pyridines |
WO2012151525A1 (en) | 2011-05-04 | 2012-11-08 | Rhizen Pharmaceuticals Sa | Novel compounds as modulators of protein kinases |
SI2870157T1 (en) | 2012-07-04 | 2018-02-28 | Rhizen Pharmaceuticals S.A. | SELECTIVE PI3K-DELTA INHIBITORS |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004048877A1 (de) * | 2004-10-07 | 2006-04-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | PI3-Kinasen |
JP5122287B2 (ja) * | 2004-10-07 | 2013-01-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Pi3キナーゼ |
UY29149A1 (es) * | 2004-10-07 | 2006-05-31 | Boehringer Ingelheim Int | Tiazolil-dihidro-indazoles |
KR20090029182A (ko) * | 2006-04-06 | 2009-03-20 | 베링거 인겔하임 인터내셔날 게엠베하 | 단백질 키나제 억제제로서 티아졸릴디하이드로인다졸 유도체 |
US20070238718A1 (en) * | 2006-04-06 | 2007-10-11 | Matthias Grauert | Thiazolyl-dihydro-indazole |
US20070259855A1 (en) * | 2006-04-06 | 2007-11-08 | Udo Maier | Thiazolyl-dihydro-indazole |
JP2009532425A (ja) | 2006-04-06 | 2009-09-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | チアゾリルジヒドロインダゾール |
-
2009
- 2009-03-11 UY UY0001031700A patent/UY31700A/es not_active Application Discontinuation
- 2009-03-11 PE PE2009000361A patent/PE20091617A1/es not_active Application Discontinuation
- 2009-03-12 TW TW098108096A patent/TW200942548A/zh unknown
- 2009-03-12 CL CL2009000599A patent/CL2009000599A1/es unknown
- 2009-03-12 AR ARP090100892A patent/AR070877A1/es unknown
- 2009-03-13 BR BRPI0908583A patent/BRPI0908583A2/pt not_active IP Right Cessation
- 2009-03-13 EP EP09719604A patent/EP2280982A1/en not_active Ceased
- 2009-03-13 KR KR1020107020481A patent/KR20100135743A/ko not_active Application Discontinuation
- 2009-03-13 WO PCT/EP2009/052959 patent/WO2009112565A1/en active Application Filing
- 2009-03-13 JP JP2010550206A patent/JP2011513471A/ja active Pending
- 2009-03-13 MX MX2010009837A patent/MX2010009837A/es not_active Application Discontinuation
- 2009-03-13 EA EA201001427A patent/EA201001427A1/ru unknown
- 2009-03-13 US US12/921,588 patent/US20110118208A1/en not_active Abandoned
- 2009-03-13 AU AU2009224659A patent/AU2009224659A1/en not_active Abandoned
- 2009-03-13 CN CN2009801164824A patent/CN102015728A/zh active Pending
- 2009-03-13 CA CA2717488A patent/CA2717488A1/en not_active Abandoned
-
2010
- 2010-08-24 IL IL207776A patent/IL207776A0/en unknown
- 2010-08-24 ZA ZA2010/06023A patent/ZA201006023B/en unknown
- 2010-09-01 CO CO10108096A patent/CO6290768A2/es not_active Application Discontinuation
- 2010-09-09 MA MA33164A patent/MA32158B1/fr unknown
- 2010-10-08 EC EC2010010532A patent/ECSP10010532A/es unknown
-
2012
- 2012-01-11 US US13/347,797 patent/US8304556B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EA201001427A1 (ru) | 2011-04-29 |
AU2009224659A1 (en) | 2009-09-17 |
CL2009000599A1 (es) | 2011-01-07 |
JP2011513471A (ja) | 2011-04-28 |
MA32158B1 (fr) | 2011-03-01 |
US20110118208A1 (en) | 2011-05-19 |
TW200942548A (en) | 2009-10-16 |
ZA201006023B (en) | 2011-10-26 |
KR20100135743A (ko) | 2010-12-27 |
AR070877A1 (es) | 2010-05-12 |
IL207776A0 (en) | 2010-12-30 |
UY31700A (es) | 2009-11-10 |
BRPI0908583A2 (pt) | 2019-09-24 |
CA2717488A1 (en) | 2009-09-17 |
US20120108567A1 (en) | 2012-05-03 |
EP2280982A1 (en) | 2011-02-09 |
PE20091617A1 (es) | 2009-11-12 |
CO6290768A2 (es) | 2011-06-20 |
CN102015728A (zh) | 2011-04-13 |
MX2010009837A (es) | 2010-09-28 |
US8304556B2 (en) | 2012-11-06 |
WO2009112565A1 (en) | 2009-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP099823A (es) | Nuevos compuestos químicos | |
ECSP12011830A (es) | Nuevos compuestos. | |
UY33199A (es) | 5-alquinil-pirimidinas. | |
UY31982A (es) | Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas | |
ECSP088932A (es) | Nuevos compuestos químicos | |
CO6341617A2 (es) | 5-alquinil-pirimidinas | |
ECSP11011079A (es) | Nuevos compuestos de hidroxiareno. | |
PE20151023A1 (es) | Triazolopirazinas | |
UY29636A1 (es) | 2,4-diamino-pirimidinas como inhibidores de aurora | |
ECSP11010816A (es) | Nuevos Compuestos | |
ECSP13012448A (es) | Nuevas aminopirazoloquinazolinas. | |
ECSP11010930A (es) | Nuevos compuestos químicos | |
CR20110216A (es) | Derivados de ácido 1-amino-2-ciclobutiletilborónico | |
UY32611A (es) | Compuestos de 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
ECSP088905A (es) | Nuevos compuestos | |
UY32494A (es) | Nuevas 2,4-diaminopirimidinas, sales farmacéuticas de las mismas, composiciones conteniéndolas y aplicaciones | |
ECSP10010532A (es) | Tiazolil-dihidro-indazoles | |
ECSP088749A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
UY29767A1 (es) | Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones | |
UY32240A (es) | Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones. | |
UY31138A1 (es) | Derivados de indolinonas sustituidas, composiciones conteniendolos y aplicaciones | |
ECSP11011558A (es) | Nuevos compuestos químicos. | |
CO6460762A2 (es) | 5-alquinil-piridinas | |
CR20120166A (es) | Composiciones y productos antimicrobianos | |
CO6460760A2 (es) | Tia-triaza-ciclopentazulenos |